Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Angler101on Mar 09, 2023 1:31pm
287 Views
Post# 35328579

This is not a short attack in combo with a hostile takeover.

This is not a short attack in combo with a hostile takeover.What we’re seeing are the mm’s dragging the share price down on low volume, because they can, and they’re being helped by people who are panicking and selling. Plain and simple. And as somebody already stated somewhere here earlier, a hostile takeover is highly unlikely, because there are simply too many players lined up that would step up with a higher bid. All the years I’ve been involved with stocks, every time I see a meteoric spike in the share price of a stock, like I believe we will soon see with ONCY,  ( Force Protection (FRPT) being another example), the spike was preceded by an unwarranted temporary precipitous drop, orchestrated by parties interested in buying up as many weak hands from retail shareholders as they can, before the invevitable impending rise. If you don’t sell, you don’t lose. Now granted, you could sell, and buy in cheaper, but the very act of selling your shares is the reason they’re able to drive the price lower in the first place. If I sold my shares, which account for more than our recent daily volume, it would likely lower the price by at least 10 additional percentage points. So please, lighten up people! Relax, go golfing or skiing, or boating,.....anything but watching the share price hour by hour, day after day.....our time is coming.....unless the institutions conducting the Bracelet Trial are suddenly hit by a freak cataclysmic meteor bombardment, we just have to be patient and wait a little longer....it won’t surprise me in the slightest to very soon see an accelerated approval announcement which will immediately bring us right back to the $2.50+ range, and then likely it will continue up from there into late April to May...

.....anyway, go ahead and sell out if you want to, but do it at your own peril. GLTA .....Angler
<< Previous
Bullboard Posts
Next >>